Seasonal Variations in Macrophages/Microglia Underlie Changes in the Mouse Model of Multiple Sclerosis Severity
- 13 July 2020
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 57 (10) , 4082-4089
Abstract
Both immune and neurodegenerative mechanisms underlie multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). MS/EAE are triggered by encephalitogenic immune cells, including Th1 and Th17 cells, whereas T regulatory (Treg) cells are involved in inflammation resolution. Pro-inflammatory macrophages/microglia also play a deleterious role in the disease. Seasonal variations in MS relapses, active lesions, and pro- and anti-inflammatory cytokine levels have been described in MS patients and have been related with both perinatal and adult exposure to sunlight and other environmental factors. However, some data in EAE mice suggest that these variations might be, at least partially, endogenously determined. Thus, our objective was to study the effect of the season of birth and disease induction on the course of EAE, and immune cell infiltration in the central nervous system (CNS) in myelin oligodendrocyte glycoprotein (MOG35–55)-induced EAE in 8 weeks old, female C57BL/6N mice maintained under constant, controlled conditions. EAE severity as well as pathogenic (Th1, Th17, macrophages/microglia) and protective (Treg) subsets was found to vary according to the season of birth or of EAE induction. Summer-born or summer-immunized animals developed a milder disease, which coincided with variations in numbers of T effector/regulatory subsets, and significantly low numbers of macrophages/microglia. These results suggest that endogenous rhythms in immune responses might cause seasonal variations in EAE severity, and, maybe, in the course of MS, and that they might be related to macrophages/microglia.Keywords
Funding Information
- Consejería de Salud, Junta de Andalucía (PI-0209-2010, PI-0485-2014 and PC-0019-2017, PC-0111-2016-0111)
- PAIDI Program of the Andalusian Government (PAIDI Program of the Andalusian Government)
- Instituto de Salud Carlos III (RD06/0013/0001 and RD12/0043/0012)
- Ministerio de Educación, Cultura y Deportes (FPU13/01210)
This publication has 46 references indexed in Scilit:
- New insights into the burden and costs of multiple sclerosis in EuropeMultiple Sclerosis Journal, 2017
- An updated histological classification system for multiple sclerosis lesionsActa Neuropathologica, 2016
- Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis PatientsPLOS ONE, 2011
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosisBrain, 2009
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple SclerosisThe American Journal of Pathology, 2008
- IL-17 Plays an Important Role in the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2006
- Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous SystemThe Journal of Immunology, 2005
- Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune EncephalomyelitisJournal of Experimental Medicine, 2004
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisNature Medicine, 2002
- Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligandNature Medicine, 2000